The board (the "Board") of directors (the "Directors") of China Shineway Pharmaceutical Group Limited (the "Company") announced that Mr. Liu Tiejun ("Mr. Liu") has tendered his resignation as an executive director of the Company with effect from 1 November 2023 in order to devote more time to focus on his role as a vice president of Shineway Pharmaceutical Group Limited (an indirect wholly-owned subsidiary of the Company). Mr. Liu has confirmed that he has no disagreement with the Board and that he is not aware of any matters in relation to his resignation as an executive director the Company need to be brought to the attention of the shareholders of the Company. The Board would like to express its sincere gratitude to Mr. Liu for his valuable contributions to the Company during his tenure of service.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.89 HKD | +1.44% | +7.15% | +36.04% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+36.04% | 943M | |
+22.69% | 43.81B | |
+25.56% | 23.01B | |
+18.00% | 15.27B | |
+8.91% | 13.68B | |
+42.72% | 11.96B | |
-7.49% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.59B |
- Stock Market
- Equities
- 2877 Stock
- News China Shineway Pharmaceutical Group Limited
- China Shineway Pharmaceutical Group Limited Announces Resignation of Executive Director